|
ZNF790 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.13579999999558E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.630500E-04 |
| Normal-vs-Stage2 |
1.567720E-02 |
| Normal-vs-Stage3 |
9.87260000000489E-05 |
| Normal-vs-Stage4 |
3.80650000000315E-05 |
| Stage1-vs-Stage2 |
9.067800E-01 |
| Stage1-vs-Stage3 |
1.438210E-01 |
| Stage1-vs-Stage4 |
3.946200E-02 |
| Stage2-vs-Stage3 |
2.696600E-01 |
| Stage2-vs-Stage4 |
7.087900E-02 |
| Stage3-vs-Stage4 |
3.848600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.83569999999889E-05 |
| Normal-vs-AfricanAmerican |
6.940000E-02 |
| Normal-vs-Asian |
1.534040E-02 |
| Caucasian-vs-AfricanAmerican |
5.464400E-01 |
| Caucasian-vs-Asian |
1.728760E-01 |
| AfricanAmerican-vs-Asian |
8.730600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.157600E-03 |
| Normal-vs-Female |
2.34359999999878E-05 |
| Male-vs-Female |
1.022020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.357400E-04 |
| Normal-vs-Age(41-60Yrs) |
4.210100E-04 |
| Normal-vs-Age(61-80Yrs) |
4.354700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.178790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.981200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.103400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.838200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.666400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.563400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.808200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.995170E-03 |
| Classical-VS-Follicular |
4.643000E-01 |
| Classical-VS-Other |
6.957200E-01 |
| Classical-VS-Normal |
1.175600E-03 |
| Tall-VS-Follicular |
9.217300E-03 |
| Tall-VS-Other |
1.795370E-01 |
| Tall-VS-Normal |
1.1019000000223E-06 |
| Follicular-VS-Other |
9.019200E-01 |
| Follicular-VS-Normal |
3.295200E-03 |
| Other-VS-Normal |
1.450440E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.403060E-03 |
| Normal-vs-N1 |
2.36829999999966E-05 |
| N0-vs-N1 |
3.170200E-02 |
|
|
